Skip to content

Clinical trials

Terminated Phase 3 Muscular Dystrophies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophies Phase: Phase 3 Status: Terminated Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20131
20141
20191
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical1
Catabasis Pharmaceuticals1
Cooperative International Neuromuscular Research Group1
Fulcrum Therapeutics1
GlaxoSmithKline1
Kyntra Bio1
PTC Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophies7
Muscular Dystrophy, Duchenne6
Musculoskeletal Diseases4
Neuromuscular Diseases4
Genetic Diseases, Inborn2
Genetic Diseases, X-Linked2
Muscular Diseases2
Muscular Disorders, Atrophic2
Nervous System Diseases2
Muscular Dystrophy, Facioscapulohumeral1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.